Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - HEALTH DISCOVERY CORPex99-1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

 
FORM 8-K
 

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  November 25, 2012


Health Discovery Corporation
(Exact name of registrant as specified in charter)


Georgia
333-62216
74-3002154
(State of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)


2 East Bryan Street, Suite 1500, Savannah, GA  31401
(Address of principal executive offices / Zip Code)


912-443-1987
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act.
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
 
o
Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act.
 
o
Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act.

 
 
 
 
 
ITEM 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On November 25, 2012, Mr. Curtis G. Anderson resigned from the Board of Directors of Health Discovery Corporation (the “Company”).  The Company is in the process of searching for a new member of the Board of Directors. A copy of Mr. Anderson’s resignation notice is attached to this Form 8-K as Exhibit 99.1.
 
Item 9.01. Financial Statements and Exhibits.
                      
(a)           Not applicable
(b)           Not applicable
(c)           Not applicable
(d)           Exhibits.
                
                99.1 Resignation Notice of Mr. Curtis G. Anderson

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




 
HEALTH DISCOVERY CORPORATION
   
 
 
 
Dated:  November 29, 2012
By:
/s/ Mark A. Moore, Ph.D.
 
   
Interim Chief Operating Officer